New research from Michigan Medicine highlights inequality in access to clinical trials and cutting-edge care for people living in socially vulnerable or disadvantaged counties across the United States. Rishi Sekar, M.D., M.S., lead researcher, explores key findings and how access to promising new treatments might be made more equitable.
